Schonfeld Strategic Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.17M | Buy |
72,945
+65,782
| +918% | +$8.27M | 0.06% | 324 |
|
2025
Q1 | $792K | Sell |
7,163
-37
| -0.5% | -$4.09K | ﹤0.01% | 1268 |
|
2024
Q4 | $983K | Sell |
7,200
-17,082
| -70% | -$2.33M | 0.01% | 1067 |
|
2024
Q3 | $2.8M | Sell |
24,282
-6,131
| -20% | -$706K | 0.02% | 634 |
|
2024
Q2 | $4.19M | Sell |
30,413
-17,281
| -36% | -$2.38M | 0.03% | 526 |
|
2024
Q1 | $6.58M | Sell |
47,694
-80,675
| -63% | -$11.1M | 0.04% | 454 |
|
2023
Q4 | $16.9M | Buy |
128,369
+99,360
| +343% | +$13.1M | 0.11% | 178 |
|
2023
Q3 | $3.26M | Sell |
29,009
-12,895
| -31% | -$1.45M | 0.03% | 578 |
|
2023
Q2 | $3.95M | Sell |
41,904
-52,258
| -55% | -$4.93M | 0.03% | 551 |
|
2023
Q1 | $9.53M | Buy |
94,162
+46,562
| +98% | +$4.71M | 0.09% | 295 |
|
2022
Q4 | $5.69M | Sell |
47,600
-21,843
| -31% | -$2.61M | 0.05% | 444 |
|
2022
Q3 | $7.38M | Buy |
69,443
+32,722
| +89% | +$3.48M | 0.06% | 406 |
|
2022
Q2 | $3.58M | Sell |
36,721
-36,986
| -50% | -$3.6M | 0.03% | 520 |
|
2022
Q1 | $6.91M | Sell |
73,707
-47,511
| -39% | -$4.45M | 0.06% | 317 |
|
2021
Q4 | $10.3M | Buy |
+121,218
| New | +$10.3M | 0.09% | 261 |
|
2021
Q3 | – | Sell |
-19,800
| Closed | -$1.93M | – | 2201 |
|
2021
Q2 | $1.93M | Buy |
+19,800
| New | +$1.93M | 0.02% | 687 |
|
2020
Q4 | – | Sell |
-36,551
| Closed | -$3.52M | – | 1713 |
|
2020
Q3 | $3.52M | Buy |
36,551
+31,592
| +637% | +$3.04M | 0.07% | 346 |
|
2020
Q2 | $605K | Buy |
4,959
+2,458
| +98% | +$300K | 0.02% | 700 |
|
2020
Q1 | $216K | Sell |
2,501
-22,183
| -90% | -$1.92M | 0.01% | 886 |
|
2019
Q4 | $2.65M | Sell |
24,684
-39,416
| -61% | -$4.24M | 0.06% | 293 |
|
2019
Q3 | $5.78M | Buy |
64,100
+26,200
| +69% | +$2.36M | 0.17% | 156 |
|
2019
Q2 | $3.2M | Sell |
37,900
-16,400
| -30% | -$1.38M | 0.11% | 213 |
|
2019
Q1 | $4.78M | Sell |
54,300
-49,489
| -48% | -$4.36M | 0.17% | 164 |
|
2018
Q4 | $7.41M | Buy |
103,789
+53,789
| +108% | +$3.84M | 0.29% | 85 |
|
2018
Q3 | $6.15M | Sell |
50,000
-5,000
| -9% | -$615K | 0.27% | 101 |
|
2018
Q2 | $5.4M | Buy |
55,000
+19,793
| +56% | +$1.94M | 0.29% | 98 |
|
2018
Q1 | $2.92M | Buy |
35,207
+4,238
| +14% | +$351K | 0.22% | 136 |
|
2017
Q4 | $2.4M | Sell |
30,969
-24,711
| -44% | -$1.92M | 0.2% | 144 |
|
2017
Q3 | $3.41M | Buy |
+55,680
| New | +$3.41M | 0.31% | 103 |
|
2017
Q2 | – | Sell |
-15,320
| Closed | -$664K | – | 695 |
|
2017
Q1 | $664K | Buy |
+15,320
| New | +$664K | 0.07% | 323 |
|
2016
Q4 | – | Sell |
-5,419
| Closed | -$274K | – | 614 |
|
2016
Q3 | $274K | Sell |
5,419
-81,244
| -94% | -$4.11M | 0.05% | 325 |
|
2016
Q2 | $3.94M | Buy |
+86,663
| New | +$3.94M | 0.88% | 17 |
|